| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000029279 |
| Receipt No. | R000033468 |
| Official scientific title of the study | Assessment of severity of post-ERCP pancreatitis by the drug pain score. |
| Date of disclosure of the study information | 2017/09/26 |
| Last modified on | 2018/10/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Assessment of severity of post-ERCP pancreatitis by the drug pain score. | |
| Title of the study (Brief title) | Post-ERCP pancreatitis and the drug pain score. | |
| Region |
|
|
| Condition | ||
| Condition | Post-ERCP pancreatitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Based on the criteria of the severity of PEP (post-ERCP pancreatitis) by the Ministry of Health, Labor and Welfare,and on the severity of PEP by DPS (Drug Pain score), (and by converting the analgesic use amount as DPS), evaluate the reliability the prediction of severity of PEP by DPS compare with the prediction of the severity of PEP by the criteria of the Ministry of Health, Labor and Welfare. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Converting analgesic use amount by DPS, establish PEP severity prediction model for reliability prediction of severity of PEP by DPS |
| Key secondary outcomes | 1,DPS shows correlation with the severity criteria of the Ministry of Health, Labor and Welfare
2, DPS shows the severity earlier than the severity criteria of the Ministry of Health, Labor and Welfare 3. Calculate the cutoff value for prediction of PEP severity by DPS |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with consent capability with usual ERCP | |||
| Key exclusion criteria | 1.minors
2.Patients who had EST. 3.Patients who are undergoing bile duct jejunostomy. 4.Pancreas / biliary stent placement. 5.Patients who had ERCP on non-hospitalization6.Patients with pancreatitis before ERCP (gallstone pancreatitis, obstructive pancreatitis, etc.). |
|||
| Target sample size | 10000 | |||
| Research contact person | |
| Name of lead principal investigator | Ryukichi akashi |
| Organization | Kumamoto City Medical Association Health Care Center |
| Division name | Endoscopy |
| Address | 5-15-12 Honjo Chuo-ku Kumamotocity |
| TEL | 096-366-2711 |
| a-kashi@krmc.or.jp | |
| Public contact | |
| Name of contact person | Ryukichi akashi |
| Organization | Kumamoto City Medical Association Health Care Center |
| Division name | Endoscopy |
| Address | 5-15-12 Honjo Chuo-ku Kumamotocity |
| TEL | 096-366-2711 |
| Homepage URL | |
| a-kashi@krmc.or.jp | |
| Sponsor | |
| Institute | Kumamoto City Medical Association Health Care Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ZEON MEDICAL INC
Boston scientific ]japan INC |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | nothing |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033468 |